MedTrace Logo

Pharmacological Modulation of the Intrarenal Pressure During Endourological Procedures in the Upper Urinary Tract

NCT00428428 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2007-11-16

No results posted yet for this study

Summary

The purpose of the study is to examine the effect of endoluminally administrated isoproterenol on pelvic pressure increase during flexible ureterorenoscopy in 14 humans. We propose that isoproterenol has potential of reducing intrarenal pressure during ureterorenoscopies. Lower intrarenal pressures may have the advantage of facilitating the procedure and reducing intraoperative complications as bleeding and infections.

Conditions

  • Kidney Stone
  • Unexplained Haematuria
  • Benignant Tumour Mass in the Upper Urinary Tract

Interventions

DRUG

Isoproterenol

ISO 0.1 microgram/ml, 8 ml/min irrigation compared to saline irrigation

Sponsors & Collaborators

  • Fredericia Hosptial

    lead OTHER

Principal Investigators

  • Palle JS Osther, PhD, MD · Dp. of Urology, Fredericia & Kolding Hospitals, Fredericia, denmark

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-02-28
Completion
2007-11-30

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00428428 on ClinicalTrials.gov